NEWS & EVENTS
The management of Impax Asset Management (AIM:IPX) will be hosting a webinar regarding the details of the acquisition plans for …READ MORE
The management of Deltex Medical Group (AIM:DEMG) ,a UK medical technology company, marketing a proprietary, minimally invasive real-time haemodynamic monitoring …READ MORE
Timely interview: https://t.co/IzQZBsPvkP
$ERGO.L @ErgomedPLC v good news as PeproStat Phase II meets key endpoints, seen to be safe. CEO 'delighted' and commercial talks ongoing.
$ASC ASOS, biggest Co on AIM, written up as a Buy in @FinancialTimes FT Money section
Write up for Mark Slater’s Growth fund in @dailytelegraph Money section. $HCM Hutch Chi Med is 10.3% of this fund.
WHY CHOOSE ED
"Once again a fabulous event for private investors, it really is a fantastic thing you do to bring companies to these events as PI's rarely get the chance to meet them and ask questions in a small and supportive environment. You (the ED team) are legend - please keep them going. "
"I am delighted to go on record that Equity Development has done a very thorough and effective job for us in the last 9 months. In that period our share price has nearly doubled, and ED has published 7 notes to explain our results, acquisitions and key announcements. It has been very useful to stimulate interest amongst private investors, many of whom I have also enjoyed meeting. The timely and incisive notes have also gone down well with institutions. Last, and by no means least, ED’s willingness to work as part of a team alongside my Broker and PR firm has meant that this is a very simple relationship to manage."
"I thoroughly enjoyed the investor evening again, and as before its good that you get such an interested audience who engage and ask us all decent questions."
"The team at ED consistently produce high quality research and highlight profitable investment opportunities, an invaluable tool for small cap investors in this under researched space."